A Material Difference
Regenity Biosciences advances new frontiers in regenerative science, turning bioabsorbable materials into life-changing solutions.
Introducing RejuvaKnee™, designed to elongate the life of a knee that has been impacted by meniscal injury. As the only FDA-cleared regenerative implant device for meniscal repair on the market, RejuvaKnee™ offers new hope to patients seeing a more comprehensive recovery of meniscus tears and degeneration.
Collagen Matrix is now
Regenity Biosciences.
As part of our vision to be the global leader in bioresorbable technologies for tissue and bone repair, we’ve rebranded as Regenity Biosciences. We’re also excited to share that we’ve acquired Polyganics. This has expanded our portfolio with versatile bioresorbable and biocompatible synthetic polymers to repair natural tissue across ENT, neurosurgery, and general surgery applications.
Mission & Values
Every day, we work to make a material difference in the lives of patients. With people’s health on the line, it’s our duty to act with urgency and diligence. It is this collective ethos that drives us each day to push the boundaries of what’s possible in tissue repair and regeneration.
Urgency
Patients depend on us delivering our products with enthusiasm, efficiency, and diligence. Our obligation and privilege is to drive urgency on patients’ behalf.
Creativity
We are passionate trailblazers, relentless in our pursuit of continuous improvement.
Determination
We are passionate, dedicated, and tenacious about our goals.
Integrity
We act in all ways with respect and transparency, ethically and honestly, with everyone. Our work represents who we are, as we create products we can proudly recommend to our loved ones.
Collaboration
We are only successful together, operating as one diverse and inclusive team with each other and our customers.
About Regenity
There’s an art and a science to regenerative science. Our scientists and inventors transform tissue healing, from product concept through commercialization. As subject matter experts in material production and processing, product development, and manufacturing, we design and produce advanced devices and implants that support the body’s natural ability to regenerate.
Products & Services
For more than 25 years, Regenity has supported clients around the world looking to accelerate time-to-market, augment their product portfolio, create new innovations, manufacture new products, and gain regulatory approval. We offer a vast array of raw materials, contract manufacturing, and contract development solutions for medical technology clients.
Technology Platforms
Applying our state-of-the-art proprietary technology platforms, we develop bioresorbable and biocompatible materials for use in a range of medical and dental applications, driving tissue regeneration and functional patient recovery.
86
Medical device approvals in 86 countries
4m+
Devices a year delivered to medical technology clients
25m
Devices produced since inception
Highlights
Read about our latest news, and download available product brochures.
Announcing Kickoff of Clinical Study for First-of-its-kind Device-drug Combination Product
February 2, 2025 – Regenity Biosciences announced the enrollment of the first…
Regenity Biosciences Completes First Surgery with RejuvaKnee™, Pioneering Meniscal Repair Innovation
Regenity Biosciences, a global leader in regenerative medicine and Linden Capital Partners…
Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee™, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care
PARAMUS, N.J., Oct. 8, 2024 /PRNewswire/ — Regenity Biosciences, a global leader in…
Regenity Biosciences Receives Regulatory Approval for Collagen Dental Membrane in China After First-of-its-Kind Breakthrough Clinical Study
Multicenter Clinical Study Demonstrates Benefits of Regenity’s Novel Crosslinked Collagen…
Natsuyo Lee Reflects on 20 Years at Regenity
Natsuyo Lee (Nat) plays a pivotal role in bringing innovation to life at Regenity Biosciences….
Dan Fernandez Returns to Regenity
Meet Daniel Fernandez, our Regulatory Specialist, whose journey is a testament to the incredible…
Congratulations Peggy Hansen
We’re thrilled to announce that our very own Peggy Hansen, General Manager, Contract…
Collagen Matrix Inc. Unveils New Brand and Name as Regenity Biosciences
The rebrand supports the company’s position as material transformers in regenerative implant…
Vice President of R&D, Dan Ammon, inaugurated into the National Academy of Engineering (NAE)
We are excited to honor and celebrate our Vice President of R&D Dan Ammon and his recent…
Collagen Matrix Names Tim Starr Chief Operating Officer
We are pleased to announce the appointment of Tim Starr as Chief Operating Officer at Collagen…
Announcing Kickoff of Clinical Study for First-of-its-kind Device-drug Combination Product
February 2, 2025 – Regenity Biosciences announced the enrollment of the first…
Regenity Biosciences Completes First Surgery with RejuvaKnee™, Pioneering Meniscal Repair Innovation
Regenity Biosciences, a global leader in regenerative medicine and Linden Capital Partners…
Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee™, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care
PARAMUS, N.J., Oct. 8, 2024 /PRNewswire/ — Regenity Biosciences, a global leader in…
Regenity Biosciences Receives Regulatory Approval for Collagen Dental Membrane in China After First-of-its-Kind Breakthrough Clinical Study
Multicenter Clinical Study Demonstrates Benefits of Regenity’s Novel Crosslinked Collagen…
Natsuyo Lee Reflects on 20 Years at Regenity
Natsuyo Lee (Nat) plays a pivotal role in bringing innovation to life at Regenity Biosciences….
Dan Fernandez Returns to Regenity
Meet Daniel Fernandez, our Regulatory Specialist, whose journey is a testament to the incredible…
Congratulations Peggy Hansen
We’re thrilled to announce that our very own Peggy Hansen, General Manager, Contract…
Collagen Matrix Inc. Unveils New Brand and Name as Regenity Biosciences
The rebrand supports the company’s position as material transformers in regenerative implant…
Vice President of R&D, Dan Ammon, inaugurated into the National Academy of Engineering (NAE)
We are excited to honor and celebrate our Vice President of R&D Dan Ammon and his recent…
Collagen Matrix Names Tim Starr Chief Operating Officer
We are pleased to announce the appointment of Tim Starr as Chief Operating Officer at Collagen…
Announcing Kickoff of Clinical Study for First-of-its-kind Device-drug Combination Product
February 2, 2025 – Regenity Biosciences announced the enrollment of the first…
Regenity Biosciences Completes First Surgery with RejuvaKnee™, Pioneering Meniscal Repair Innovation
Regenity Biosciences, a global leader in regenerative medicine and Linden Capital Partners…
Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee™, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care
PARAMUS, N.J., Oct. 8, 2024 /PRNewswire/ — Regenity Biosciences, a global leader in…
Regenity Biosciences Receives Regulatory Approval for Collagen Dental Membrane in China After First-of-its-Kind Breakthrough Clinical Study
Multicenter Clinical Study Demonstrates Benefits of Regenity’s Novel Crosslinked Collagen…
Natsuyo Lee Reflects on 20 Years at Regenity
Natsuyo Lee (Nat) plays a pivotal role in bringing innovation to life at Regenity Biosciences….
Dan Fernandez Returns to Regenity
Meet Daniel Fernandez, our Regulatory Specialist, whose journey is a testament to the incredible…
Congratulations Peggy Hansen
We’re thrilled to announce that our very own Peggy Hansen, General Manager, Contract…
Collagen Matrix Inc. Unveils New Brand and Name as Regenity Biosciences
The rebrand supports the company’s position as material transformers in regenerative implant…
Vice President of R&D, Dan Ammon, inaugurated into the National Academy of Engineering (NAE)
We are excited to honor and celebrate our Vice President of R&D Dan Ammon and his recent…
Collagen Matrix Names Tim Starr Chief Operating Officer
We are pleased to announce the appointment of Tim Starr as Chief Operating Officer at Collagen…
Careers
Looking for a career with purpose? Join our team and work with us to develop life-changing products that help patients heal. Visit our careers page to learn more about what sets Regenity apart.
